Tag:
Ofirmev
Latest Headlines
Latest Headlines
Cadence wins FDA approval for pain, fever injection
The FDA has approved Cadence Pharmaceuticals' ( $CADX ) Ofirmev injection (acetaminophen) for the treatment of management of mild to moderate pain, the management of moderate to severe pain with
Cadence shares surge in plans to resubmit pain therapy NDA
Shares of Cadence Pharmaceuticals ( CADX ) surged this morning after the developer said that it plans to resubmit its marketing application for the pain therapy Ofirmev within 30 days. Citing problems
FDA puts Cadence pain drug app on hold
The FDA has put Cadence Pharma's application to market its pain and fever therapy on hold. The agency alerted Cadence that it couldn't approve the drug--to be marketed as Ofirmev--until manufacturing
